SHORT SUMMARY:
"This is a 68-year-old man with a history of BPH and prostate cancer, presenting for a follow-up appointment. He reports stable urinary symptoms and is tolerating his medications well."
CHIEF COMPLAINT:
[[Patient presents to the office today to discuss:
1. Benign Prostatic Hyperplasia (BPH)
2. Prostate Cancer
3. Erectile Dysfunction]]
PAST UROLOGICAL HISTORY:
"Mr. John Smith is a 68-year-old man with a history of BPH diagnosed five years ago, managed with tamsulosin. He underwent a radical prostatectomy for prostate cancer two years ago, with subsequent adjuvant radiation therapy. PSA levels have been stable for the past year. He is a retired accountant and enjoys gardening. He is followed by Dr. Jane Doe, a radiation oncologist. He takes tamsulosin 0.4mg daily and has no known allergies."
HPI TODAY 01 November 2024:
- Reports no significant changes in urinary frequency, urgency, or nocturia.
- Denies any new onset of urinary symptoms, hematuria, or incontinence.
- PSA level drawn today, results pending.
- No AUA symptom score performed.
- No PVR performed.
- PSA density not calculable.
PMH, PSH, MEDS, ALLERGIES, SH, and FH:
- PMH: Hypertension, Hyperlipidemia, Prostate Cancer, BPH
- PSH: Radical Prostatectomy (2 years ago), Appendectomy (childhood)
- MEDS: Tamsulosin 0.4mg daily, Atorvastatin 20mg daily, Lisinopril 10mg daily
- ALLERGIES: NKDA
- SH: Non-smoker, occasional alcohol use, denies illicit drug use.
- FH: Father with prostate cancer.
PHYSICAL EXAMINATION:
[Constitutional: Appears well-developed, well-nourished man in no acute distress. Alert and oriented.
Psychiatric: Mood and affect appropriate. Cooperative and pleasant.
GU exam if performed: Digital rectal exam reveals no palpable masses or nodules. Prostate is firm, with no areas of induration. Testes are normal bilaterally. No hernias noted.]
ASSESSMENT AND PLAN:
Patient is a 68-year-old man with a history of BPH and prostate cancer, currently in remission. He presents for routine follow-up.
1. Benign Prostatic Hyperplasia (BPH) (ICD-10 Code: N40.9)
- Assessment: Stable urinary symptoms, well-controlled with medication.
- Plan: Continue tamsulosin 0.4mg daily. Medication regimen reviewed, including risks, benefits, adherence, and need for adjustments. Decision made to continue tamsulosin 0.4mg daily based on patient's condition and response to treatment.
- Counseling: Discussed the importance of medication adherence and potential side effects.
2. Prostate Cancer (ICD-10 Code: C61)
- Assessment: PSA stable, no evidence of recurrence.
- Plan: Continue with PSA monitoring every 6 months. Medication regimen reviewed, including risks, benefits, adherence, and need for adjustments. Decision made to continue Atorvastatin 20mg daily based on patient's condition and response to treatment.
- Counseling: Discussed the importance of continued surveillance and potential long-term side effects of treatment.
3. Erectile Dysfunction (ICD-10 Code: N52.0)
- Assessment: Patient reports mild erectile dysfunction.
- Plan: Discussed treatment options, including PDE5 inhibitors. Medication regimen reviewed, including risks, benefits, adherence, and need for adjustments. Decision made to initiate sildenafil 50mg as needed based on patient's condition and response to treatment.
- Counseling: Discussed lifestyle modifications and potential side effects of medication.
ORDERS:
[PSA, Urinalysis]
FOLLOW UP:
[Follow-up in 6 months for PSA and symptom review. Return sooner if any new symptoms develop.]
SHORT SUMMARY:
"This is a 68-year-old man with a history of BPH and prostate cancer, presenting for a follow-up appointment. He reports stable urinary symptoms and is tolerating his medications well."
Consent:
“Consent for the use of AI-assisted tools for documentation was obtained from the patient and all other participants in the visit prior to this encounter. All questions were answered. Patient understands that they may decline the use of AI-assisted tools.”
